跳到主要导航
跳到搜索
跳到主要内容
Pure University (For Demo Only) 国内
帮助和常见问题
English
中文
国内
简介
研究单位
科研成果
设备
数据集
活动
奖项
影响
项目
新闻 / 媒体
按专业知识、名称或附属进行搜索
联系专家
查看 Scopus 资料
Cerný Vladimír
Professor
Dalhousie University
,
Business, Management and Accounting
电子邮件
CV271338
dal
ca
网站
https://www.scopus.com/authid/detail.url?authorId=7102271338
h-index
h10-index
h5-index
7331
引用
33
H-指数
根据存储在 Pure 中的刊物数量以及来自 PlumX 的引用文献数量进行计算
3266
引用
24
H-指数
根据储存在 Pure 的刊物以及来自 Scopus 的引用文献数量计算
698
引用
11
H-指数
根据储存在 Pure 的刊物以及来自 Scopus 的引用文献数量计算
1997 …
2023
每年的科研成果
综述
指纹
网络
科研成果
(441)
新闻 / 媒体
(26)
相似简介
(6)
指纹
深入其中 Cerný Vladimír 为活跃的研究主题。这些主题标签来自此人的成果。它们共同形成唯一的指纹。
分类
加权
按字母排序
Medicine and Dentistry
Microcirculation
100%
Intensive Care
61%
Sepsis
48%
Heart Arrest
48%
Observational Study
47%
Glycocalyx
46%
Acute Respiratory Distress Syndrome
39%
Anesthesiology
36%
Intensive Care Medicine
35%
Artificial Respiration
35%
Resuscitation
31%
Intensive Care Unit
28%
COVID-19
26%
General Anesthesia
26%
Injury
25%
Bleeding
22%
Hypotension
22%
Disease
21%
Hospital-Acquired Pneumonia
19%
Ventilator Weaning
19%
Dexmedetomidine
19%
Hypothermia
19%
Experimental Endotoxemia
19%
Anesthesia Induction
17%
Coagulopathy
17%
Cytokine
16%
Diagnosis
16%
Health Care
16%
Out of Hospital Cardiac Arrest
15%
Emergency Care
15%
Organ Donor
15%
Lipopolysaccharide
15%
Cohort Effect
15%
Brain Death
15%
Midazolam
14%
Clinical Study
14%
Volunteer
14%
Blood Pressure
14%
Terlipressin
14%
Prospective Study
14%
Continuous Positive Airway Pressure
13%
Capillary
13%
Decision Making
13%
Chronic Thromboembolic Pulmonary Hypertension
13%
Cannabinoid 1 Receptor
13%
Tracheotomy
13%
Levosimendan
13%
Sodium Chloride
13%
Cadaver
13%
Blood Transfusion
13%
Pharmacology, Toxicology and Pharmaceutical Science
Sepsis
73%
Observational Study
58%
Adult Respiratory Distress Syndrome
39%
Injury
39%
Septic Shock
32%
Bleeding
30%
Cytokine
26%
Experimental Sepsis
26%
Disease
25%
Prevalence
23%
Blood Clotting Factor 7
19%
Hospital Acquired Pneumonia
19%
Brain Death
18%
Peritonitis
18%
Antibiotic Agent
17%
Hypotension
16%
Prospective Study
16%
Hypertensive Factor
14%
Terlipressin
14%
Lipopolysaccharide
13%
Critical Illness
13%
Infection
13%
Chronic Thromboembolic Pulmonary Hypertension
13%
Cannabinoid 1 Receptor
13%
Heart Arrest
13%
Tamoxifen
13%
Cohort Study
13%
Brain Injury
13%
Blood Clotting Disorder
13%
Vasopressin
13%
Postpartum Hemorrhage
13%
Neuromuscular Blocking Agent
13%
Lung Edema
13%
Sodium Chloride
13%
Chronic Obstructive Lung Disease
13%
Tumor Necrosis Factor
12%
Acetylsalicylic Acid
12%
Intravital Microscopy
12%
Inflammation
11%
Adverse Event
11%
Antibiotic Therapy
10%
Normal Human
9%
Hypothermia
9%
Syndrome
9%
Cadaver
9%
Carbetimer
8%
Asthma
8%
Muscle Fatigue
8%
Toxic Injury
8%
Anemia
8%
Keyphrases
Czech Republic
20%
Critically Ill Patients
20%
Prospective Observational Study
19%
Sepsis
18%
Cannabinoid Receptor 1 (CB1R)
17%
Endothelial Glycocalyx
15%
Clinical Application
14%
Cardiogenic Pulmonary Edema
13%
Levosimendan
13%
Acute Respiratory Distress Syndrome
13%
Induced Hypothermia
13%
Terlipressin
13%
Experimental Sepsis
13%
Perfused Boundary Region
11%
Functional Capillary Density
11%
Intensive Care Medicine
9%
Sidestream Dark Field Imaging
9%
Cardiac Surgery
9%
Hypotension
8%
Clinical Approach
8%
CB1R Antagonist
8%
Tracheostomy
8%
Antibiotics
8%
Sublingual Microcirculation
8%
Septic Shock
8%
Intensive Care Unit
8%
LUNG SAFE
7%
Orthogonal Polarization Spectral Imaging
7%
Intestinal Microcirculation
7%
Preanesthetic Evaluation
7%
First Aid
7%
Capillary Perfusion
7%
Pentobarbital
7%
Anesthesiology
7%
Mechanical Ventilation
6%
Left Atrial Function
6%
Elderly Patients
6%
Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
6%
Healthcare Referral
6%
Monitoring Planning
6%
Acute Disseminated Encephalomyelitis
6%
Therapeutic Temperature
6%
Acute Critical Illness
6%
Laboratory Medicine
6%
Delayed Contrast Enhancement
6%
Contrast-enhanced Cardiac Magnetic Resonance
6%
Meropenem
6%
Cumulative Fluid Balance
6%
Parental Support
6%
Extended Infusion
6%
